Viking Therapeutics (VKTX) Q1 2023 Earnings

26AprConfirmed
Jul 22
Q3 2022
Q4 2022
Q1 2023
-0.26
-0.24
-0.23
-0.21

Details

Expected EPS
-0.24
Actual EPS
-0.25
Surprise EPS
-0.01
Surprise Percent
+4.17%

Description

Viking Therapeutics (VKTX) has reported earnings of -0.25 per share for Q1 2023.

0 Comments

Share your thoughts